Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine

• Egile Nagusiak: Irwin K. Cheah (Egilea), Richard M. Y. Tang (Egilea), Xiaoyuan Wang (Egilea), Karishma Sachaphibulkij (Egilea), Suet Yen Chong (Egilea), Lina H. K. Lim (Egilea), Jiong-Wei Wang (Egilea), Barry Halliwell (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<b><i>Background:</i></b> Anthracyclines such as doxorubicin remain a primary treatment for hematological malignancies and breast cancers. However, cardiotoxicity induced by anthracyclines, possibly leading to heart failure, severely limits their application. The pathological...